Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Tyulpakov AN. The role of molecular genetics in the diagnosis and treatment of endocrine diseases. A brief description of the monogenic forms of hereditary endocrinopathies diagnosed in Endocrinological Research Center FGU ENC during the 15-year period (1996-2010). Problemi Endokrinologіji. 2011;1:26-34. (In Russian). doi: 10.14341/probl201157126-34.
Aslan IR, Ranadive SA, Valle I, et al. The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus. J Obes (Lond). 2014 Jan;38(1):148-51. doi: 10.1038/ijo.2013.53.
Tyulpakov AN, Kalynchenko NYu. Clinical and molecular-genetic characteristics of 10 cases with congenital adrenal hypoplasia caused by DAX1 gene defects. Problemi Endokrinologіji. 2010;2:3-9. (In Russian). doi: 10.14341/probl20105623-9.
Amiraslanova MM, Mamedova NF, Sosnova EA. The role of 21-hydroxylase deficiency in the genesis of congenital adrenal hyperplasia. Nauchnye vedomosty Belgorodskogo gosudarstvennogo universyteta. Seriya: Meditsina. Farmatsiya. 2011;10(105):44-7. (In Russian).
Zelynskaya NB, Pohadaeva NL, Hloba EV, Shevchenko YYu, Behutova TN, Khoroshaya OA, Malashonok VB. The state of the hormonal status of children with congenital adrenocortical dysfunction due to deficiency of 21-hydroxylase. Perinatologiya i pediatriya. 2015;1(61):54-9. (In Russian). doi: 10.15574/PP.2015.61.54.
Shozu M, Fukami M, Ogata T. Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis. Expert Rev Endocrinol Metab. 2014;9(4):397-409. doi: 10.1586/17446651.2014.926810.
Kalinchenko NYu, Zubkova NA, Tyulpakov AN. Clinical description and molecular-genetic verification of 2 cases of isolated mineralocorticoid insufficiency due to a deficiency of aldosterone synthase. Problemi Endokrinologіji. 2009;1:28-31. (In Russian).
Vitebskaya AV, Petryaikina EE, Razumovsky AYu, et al. A case of severe neonatal hyperparathyroidism due to defect in calcium receptor. Problemi Endokrinologіji. 2010;4:27-33. (In Russian). doi: org/10.14341/probl201056427-33.
Hannan FM, Nesbit MA, Zhang C, et al. Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. Hum Molec Genet. 2012:21:2768-78 PubMed: 22422767. doi: 10.1093/hmg/dds105.
Inden M, Iriyama M, Zennami M. The type III transporters (PiT-1 and PiT-2) are the major sodium-dependent phosphate transporters in the mice and human brains. Brain Res. 2016;15,1637:128-36. doi: 10.1016/j.brainres.2016.02.032.
Laryna AA, Troshyna EA, Yvanova ON. Autoimmune polyglandular syndromes in the adults: genetic and immunological diagnostic criteria. Problemi Endokrinologіji. 2014;60(3):43-52. (In Russian). doi: 10.14341/probl201460343-52.
Turton JP, Reynaud R, Mehta A, et al. Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab. 2005;90:8:4762-70. doi: 10.1210/jc.2005-0570.
Kolodkina AA, Karmanov ME, Kalinchenko NYu, et al. The clinical, hormonal and molecular genetic characteristics of three cases of impaired sex formation (NFP) 46XY, caused by a deficiency of 5-reductase type II. Problemi Endokrinologіji. 2010;3:34-40. (In Russian). doi: 10.14341/probl201056334-40.
Dedov YY, Zubkova NA, Arbatskaya NYu, et al. MODY type 2: clinical and molecular-genetic characteristics of 13 cases of the disease. The first description of MODY in Russia. Problemi Endokrinologіji. 2003;3:3-7. (In Russian). doi: 10.14341/probl20095533-7.
Ellard S, Ellard S, Lango H Allen, De Franco E, et al. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia. 2013;56(9):1958-63. doi: 10.1007/s00125-013-2962-5.
Alghamdi AB, Alsaedi KA, Aljasser A, Altawil A, Naglaa M Kamal. Extended clinical features associated with novel Glis3 mutation: a case report. BMC Endocrine Disorders. 2017;17:14. doi: 10.1186/s12902-017-0160-z.
Peterkova VA, Vasyukova OV, Tyul'pakov AN. Non-immune thyrotoxicosis caused by an activating mutation of the thyrotropic hormone receptor gene (the first description in Russia). Problemi endokrynologiji. 2009;2:48-50. (In Russian). doi: 10.14341/probl200955248-50.
Wang F, Liu C, Jia X, et al. Next-generation sequencing of NKX2.1, FOXE1, PAX8, NKX2.5, and TSHR in 100 Chinese patients with congenital hypothyroidism and athyreosis. Clin Chim Acta. 2017;25(470):36-41. doi: 10.1016/j.cca.2017.04.020.